Cargando…
Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
INTRODUCTION: The tumor necrosis factor (TNF-α) was initially described as lymphotoxin or cachectin. The discovery of therapies blocking the action of TNF-α, in 1988, started a new era in the therapy. One of often reported adverse effects related to the use of TNF-α antagonists is induction of the f...
Autores principales: | Pirowska, Magdalena M., Goździalska, Anna, Lipko-Godlewska, Sylwia, Obtułowicz, Aleksander, Sułowicz, Joanna, Podolec, Katarzyna, Wojas-Pelc, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565839/ https://www.ncbi.nlm.nih.gov/pubmed/26366147 http://dx.doi.org/10.5114/pdia.2015.53320 |
Ejemplares similares
-
The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis
por: Pirowska, Magdalena, et al.
Publicado: (2018) -
Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome
por: Pirowska, Magdalena, et al.
Publicado: (2019) -
The flare-up phenomenon: recurrence of distant dermatitis during patch testing
por: Obtułowicz, Aleksander, et al.
Publicado: (2016) -
Coexistence of Parry-Romberg syndrome with homolateral segmental vitiligo
por: Janowska, Marta, et al.
Publicado: (2013) -
Diagnostic accuracy of reflectance confocal microscopy for pigmented skin lesions presenting dermoscopic features of cutaneous melanoma
por: Podolec, Katarzyna, et al.
Publicado: (2019)